Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$4.00 -0.10 (-2.48%)
As of: Nov 11, 2026 · 11:21 AM EST

Tonix Pharmaceuticals Holding (TNXP) Net Equity Issued and Repurchased (2010 - 2026)

Updated

Tonix Pharmaceuticals Holding (TNXP) reported Net Equity Issued and Repurchased of $33.51 million for Q2 2026, up 204.8% from $10.99 million a year earlier and up 65.8% from the prior quarter.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Tonix Pharmaceuticals Holding's Net Equity Issued and Repurchased came in at $207.71 million, up 4.0% year-over-year; for FY2025, it came in at $224.18 million, up 59.9% from FY2024.

  • Net Equity Issued and Repurchased has a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
  • By year, Net Equity Issued and Repurchased came in at $140.22 million in FY2024 (+408.5%), $27.58 million in FY2023 (-68.6%), $87.84 million in FY2022 (-58.7%) and $212.49 million in FY2021 (+72.6%).
  • Five-year quarterly Net Equity Issued and Repurchased spans a low of -$11.5 million in Q1 2023 and a high of $94.86 million in Q3 2025.
  • Year over year, Net Equity Issued and Repurchased gained in five of the last seven quarters, with growth averaging 141.9%.
  • The high point for year-over-year Net Equity Issued and Repurchased in five years was Q2 2024 (growth of 942.8%); the low point was Q2 2023 (a decline of 97.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $20.21 million (Q1 2026), $59.14 million (Q4 2025) and $94.86 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Tonix Pharmaceuticals Holding 78.52 Mn -653.62 Mn 15.98 Mn 28.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 28.28 Mn
Jun 30, 2026 33.51 Mn
Mar 31, 2026 20.21 Mn
Dec 31, 2025 59.14 Mn
Sep 30, 2025 94.86 Mn
Jun 30, 2025 10.99 Mn
Mar 31, 2025 59.18 Mn
Dec 31, 2024 85.86 Mn
Sep 30, 2024 43.61 Mn
Jun 30, 2024 10.73 Mn
Mar 31, 2024 23,000.00
Dec 31, 2023 31.77 Mn
Sep 30, 2023 6.27 Mn
Jun 30, 2023 1.03 Mn
Mar 31, 2023 -11.50 Mn
Dec 31, 2022 7.23 Mn
Sep 30, 2022 26.88 Mn
Jun 30, 2022 44.93 Mn
Mar 31, 2022 13.06 Mn
Dec 31, 2021 43.77 Mn
API Access

Tonix Pharmaceuticals Holding Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TNXP&period=max&api_key=YOUR_API_KEY